Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Celgene to buy Juno for 9 billion dollar to boost cancer pipeline

      Celgene to buy Juno for 9 billion dollar to boost cancer pipeline

      Ruby Khatun Khatun25 Jan 2018 9:30 AM IST
      Celgene Corp will pay $9 billion in cash to buy experimental cancer drugmaker Juno Therapeutics Inc, bulking up its developmental pipeline as it works...
      Mankind Pharma 15 percent Stake Sale to take Valuation to 3.3 Billion Dollars

      Mankind Pharma 15 percent Stake Sale to take Valuation to 3.3 Billion Dollars

      Ruby Khatun Khatun24 Jan 2018 2:43 PM IST
      MUMBAI: Leading generic drug manufacturer Mankind Pharmaceuticals is now looking to sell parts of its shareholding taking its estimated valuation to...
      NPPA fixes retail price of 5 formulations

      NPPA fixes retail price of 5 formulations

      Ruby Khatun Khatun24 Jan 2018 11:00 AM IST
      New Delhi: National drug pricing regulator NPPA said it has fixed the retail prices of five formulations including those used for the treatment of...
      Omron Healthcare India eyes 45 percent revenue growth in FY 18-19

      Omron Healthcare India eyes 45 percent revenue growth in FY 18-19

      Ruby Khatun Khatun24 Jan 2018 10:36 AM IST
      New Delhi: Japanese medical devices maker Omron Healthcare is targeting around 45 percent rise in revenues at Rs 189 crore in the next fiscal year...
      Biotech mergers and acquisitions takes off as Sanofi and Celgene spend 20 billion dollars

      Biotech mergers and acquisitions takes off as Sanofi and Celgene spend 20 billion dollars

      Ruby Khatun Khatun24 Jan 2018 10:17 AM IST
      Biotech deal activity exploded on Monday with French drugmaker Sanofi and U.S.-based Celgene spending a combined total of more than $20 billion to add...
      FDAs tobacco stance faces test with Philip Morris iQOS device

      FDA's tobacco stance faces test with Philip Morris iQOS device

      Ruby Khatun Khatun24 Jan 2018 10:05 AM IST
      WASHINGTON: In a decision expected to test the Trump administration’s approach to tobacco regulation, U.S. health advisers will vote this week on...
      Tevas asthma treatment fails late-stage studies

      Teva's asthma treatment fails late-stage studies

      Ruby Khatun Khatun24 Jan 2018 9:47 AM IST
      Teva Pharmaceutical Industries said two late-stage studies testing its treatment for asthma did not meet their main goals.The studies were testing...
      30 year old medical representative shot dead in Kanpur

      30 year old medical representative shot dead in Kanpur

      Ruby Khatun Khatun23 Jan 2018 10:36 AM IST
      Kanpur: A 30-year-old medical representative was shot dead by two unidentified persons in the Kagzi- Mohal locality in the Bajaria area here, police...
      Morepen Labs reports 107 percent increase in Q3, net profit at Rs 9.67 crores

      Morepen Labs reports 107 percent increase in Q3, net profit at Rs 9.67 crores

      Ruby Khatun Khatun23 Jan 2018 10:30 AM IST
      New Delhi: Morepen Laboratories Ltd has reported yet another growth-filled quarter by registering 107 percent rise in its net profit in Q3 of FY...
      CMFRI to expand research to tap pharma prospects of marine life

      CMFRI to expand research to tap pharma prospects of marine life

      Ruby Khatun Khatun23 Jan 2018 10:15 AM IST
      Kochi: The Central Marine Fisheries Research Institute (CMRI) here has decided to expand research network to tap pharmaceutical prospects of marine...
      Allocate more funds, increase expenditure: Health experts

      Allocate more funds, increase expenditure: Health experts

      Ruby Khatun Khatun23 Jan 2018 10:00 AM IST
      New Delhi: With the Union Budget around the corner, two health experts have urged the government to allocate more funds to sectors such as family...
      Astrazeneca gets approval for Fasenra in Japan

      Astrazeneca gets approval for Fasenra in Japan

      Ruby Khatun Khatun23 Jan 2018 9:45 AM IST
      AstraZeneca and its global biologics research and development arm, MedImmune, announced that the Japanese Ministry of Health, Labour and Welfare has...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok